We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
-16.63%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$589M
AUM Growth
-$370M
(-39%)
Cap. Flow
-$220M
Cap. Flow
% of AUM
-37.27%
Top 10 Holdings %
Top 10 Hldgs %
49.75%
Holding
105
New
23
Increased
20
Reduced
14
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$18.6M |
| 2 |
Cheniere Energy
LNG
|
+$16.1M |
| 3 |
Centene
CNC
|
+$13.6M |
| 4 |
Aramark
ARMK
|
+$13M |
| 5 |
Olin
OLN
|
+$8.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$38.9M |
| 2 |
Alcoa
AA
|
+$33.1M |
| 3 |
United Rentals
URI
|
+$24.6M |
| 4 |
Teck Resources
TECK
|
+$19.4M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.25% |
| 2 | Financials | 9.87% |
| 3 | Consumer Discretionary | 8.67% |
| 4 | Industrials | 8.18% |
| 5 | Communication Services | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tandem Diabetes Care
TNDM
$1.29B
| $7.01M | 1.19% |
118,500
-53,900
| -31% | -$4.42M |
|
27
PUT
Bank of America
BAC
$441B
| $7M | 1.19% |
+225,000
| New | +$8.1M |
|
28
Intercontinental Exchange
ICE
$84.1B
| $6.58M | 1.12% |
+70,000
| New | +$7.48M |
|
|
29
Olin
OLN
$2.14B
| $6.56M | 1.11% |
+141,649
| New | +$8.18M |
|
|
30
Teck Resources
TECK
$32.4B
| $6.35M | 1.08% |
207,850
-492,000
| -70% | -$19.4M |
|
|
SBNY
31
DELISTED
Signature Bank
SBNY
| $6.27M | 1.06% |
35,000
+10,000
| +40% | +$2.24M |
|
32
Haemonetics
HAE
$3.86B
| $6.22M | 1.06% |
+95,500
| New | +$5.65M |
|
|
DFS
33
DELISTED
Discover Financial Services
DFS
| $6.15M | 1.04% |
65,000
+8,035
| +14% | +$860K |
|
34
CALL
Guardant Health
GH
$21.1B
| $6.05M | 1.03% |
150,000
+50,000
| +50% | +$2.48M |
|
35
Wells Fargo
WFC
$265B
| $5.88M | 1% |
150,000
-30,000
| -17% | -$1.32M |
|
36
PUT
Alnylam Pharmaceuticals
ALNY
$28.9B
| $5.64M | 0.96% |
38,700
+1,600
| +4% | +$227K |
|
37
DexCom
DXCM
$31.3B
| $5.54M | 0.94% |
+74,400
| New | +$6.79M |
|
38
Blackrock
BLK
$175B
| $5.48M | 0.93% |
+9,000
| New | +$5.86M |
|
|
39
Bank of America
BAC
$441B
| $5.45M | 0.92% |
+175,000
| New | +$6.3M |
|
40
Beyond Air
XAIR
$4.01M
| $5.22M | 0.89% |
1,951
| – | – |
|
41
American Vanguard Corp
AVD
$73.5M
| $4.5M | 0.76% |
+201,400
| New | +$4.51M |
|
|
SNV
42
DELISTED
Synovus
SNV
| $4.15M | 0.7% |
115,000
-45,000
| -28% | -$1.86M |
|
43
Dollar Tree
DLTR
$24.9B
| $4.13M | 0.7% |
26,500
+12,500
| +89% | +$1.98M |
|
|
WNS
44
DELISTED
WNS Holdings
WNS
| $3.8M | 0.64% |
50,874
+10,874
| +27% | +$831K |
|
45
Sol-Gel Technologies
SLGL
$284M
| $3.41M | 0.58% |
83,280
| – | – |
|
46
Great Elm Group
GEG
$69.9M
| $2.96M | 0.5% |
1,379,049
+120,000
| +10% | +$240K |
|
|
MSAC
47
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $2.93M | 0.5% |
300,000
| – | – |
|
48
Apollo Global Management
APO
$73.7B
| $2.91M | 0.49% |
60,000
-40,000
| -40% | -$2.18M |
|
49
Praxis Precision Medicines
PRAX
$10.3B
| $2.83M | 0.48% |
77,066
+49,433
| +179% | +$5.28M |
|
50
KKR & Co
KKR
$92.8B
| $2.78M | 0.47% |
+60,000
| New | +$3.15M |
|
Similar funds
GC
ICP
SAA
GIG
SI
PAMI
BDP
DWP
Kingdon Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Kingdon Capital Management held 105 positions worth $589M, down 39% from $959M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Kingdon Capital Management withdrew a net $220M in Q2 2022, closing 36 positions and reducing 14 holdings. Its most notable exit was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $38.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Kingdon Capital Management opened a new position in Humana worth $19.6M.
- Kingdon Capital Management's largest Q2 2022 buy was Humana: 41,900 shares worth $19.6M.
- Kingdon Capital Management added most to Bloomin' Brands in Q2 2022, an estimated $7.04M increase.
- Kingdon Capital Management's biggest Q2 2022 reduction was Teck Resources, cutting an estimated $19.4M.
- Kingdon Capital Management fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q2 2022, selling an estimated $38.9M.
- Kingdon Capital Management's ten largest holdings make up 50% of its $589M portfolio in Q2 2022.
- Kingdon Capital Management opened 23 new positions and closed 36 in Q2 2022.
- Kingdon Capital Management's portfolio value fell 39% quarter-over-quarter to $589M.
Based on Kingdon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.